What's Next For Moderna Stock?
Toward the end of next month, the coronavirus vaccine magnate Moderna (NASDAQ: MRNA) will report its fourth-quarter earnings, and it's bound to have implications for the company's stock price. The trouble is that Moderna doesn't have too many avenues with which it could justify higher valuations.